drugset / Trial / NCT03372239

Oral Bioavailability,and Food Effect Study and Single Ascending Dose PK Study in Healthy Male Volunteers

NCT03372239

Phase 1 Completed 48 enrolled NewLink Genetics Corporation
RandomizedCrossoverQuadruple-blindTreatment

Summary

This 2-part study will assess the effect of formulation and food on the pharmacokinetics of Indoximod in healthy volunteers. Part 1 is an open-label, 3-period, 6-sequence study. Participants will receive single doses of Indoximod base or salt formulation, in the fasted or fed state. Part 2 is a randomized single ascending dose study of indoximod salt formulation to characterize the PK profile and determine the safety and tolerability of each dose in healthy male volunteers.

Timeline

Start
2017-11-21
Primary completion
2018-01-25
Completion
2018-04-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Indoximod Small molecule

Indications

No indication recorded.